Lumayag, Rodolfo M.
HRN: 18-71-24 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2026
CEFTAZIDIME 1GM (VIAL)
04/17/2026
04/24/2026
IV
2g
Q8
Cap MR
Checking Initial Appropriateness
04/17/2026
AZITHROMYCIN 500MG TABLET (TAB)
04/17/2026
04/20/2026
ORAL
500
OD
Cap MR
Checking Initial Appropriateness
04/17/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/17/2026
04/17/2026
IV
4.5g
Now As LD
CAP HR
Checking Initial Appropriateness
04/17/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/17/2026
04/23/2026
IV
2.25g
Q6h
CAP-HR
Checking Initial Appropriateness
04/17/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/17/2026
04/23/2026
IV
2.25g
Q6h
CAP-HR
Checking Initial Appropriateness
04/20/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/20/2026
04/27/2026
IV
4.5g
Q8H
Pneumonia
Checking Initial Appropriateness
04/26/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/26/2026
05/03/2026
IV
1000mg
Q24
Cap HR
Checking Initial Appropriateness
05/04/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/04/2026
05/05/2026
IV
1000mg
Od
Cap Hr
Checking Initial Appropriateness
05/14/2026
RIFAXIMIN 200MG (TAB)
05/14/2026
05/21/2026
PER NGT
200mg
TID
Bleeding Doverticulitis
Checking Initial Appropriateness